Comparative economic evaluation of dutasteride versus finasteride for Medicare-aged men with benign prostatic hyperplasia

被引：0
|
作者：
Lin, P. J.
Shah, M.
Davis, E. A.
Hogue, S. L.
机构：
[1] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[2] Univ N Carolina, GSK, Chapel Hill, NC USA
[3] Xcenda, Palm Harbor, FL USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70961-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A305 / A305
页数：1
相关论文
共 50 条
  • [1] A prospective, comparative study of the onset of symptomatic benefit of dutasteride versus finasteride in men with benign prostatic hyperplasia in everyday clinical practice
    Hagerty, J
    Ginsberg, PC
    Metro, MJ
    Harkaway, RC
    JOURNAL OF UROLOGY, 2004, 171 (04): : 356 - 356
  • [2] Economic evaluation of finasteride in benign prostatic hyperplasia treatment
    Nickel, JC
    McDonald, H
    Hux, M
    Brisson, M
    Bernard, L
    JOURNAL OF UROLOGY, 2004, 171 (04): : 35 - 36
  • [3] An economic evaluation of finasteride for treatment of benign prostatic hyperplasia
    Baladi, JF
    Menon, D
    Otten, N
    PHARMACOECONOMICS, 1996, 9 (05) : 443 - 454
  • [4] Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
    Laanani, Moussa
    Weill, Alain
    Jollant, Fabrice
    Zureik, Mahmoud
    Dray-Spira, Rosemary
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
    Moussa Laanani
    Alain Weill
    Fabrice Jollant
    Mahmoud Zureik
    Rosemary Dray-Spira
    Scientific Reports, 13
  • [6] THE EFFECT OF FINASTERIDE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
    GORMLEY, GJ
    STONER, E
    BRUSKEWITZ, RC
    IMPERATOMCGINLEY, J
    WALSH, PC
    MCCONNELL, JD
    ANDRIOLE, GL
    GELLER, J
    BRACKEN, BR
    TENOVER, JS
    VAUGHAN, ED
    PAPPAS, F
    TAYLOR, A
    BINKOWITZ, B
    NG, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17): : 1185 - 1191
  • [7] Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride
    Khedmati, Jamaleddin
    Soleymani, Fatemeh
    Moosivand, Asiye
    Zartab, Saman
    Seyedifar, Meysam
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (01): : 206 - 215
  • [8] SPECIFIC ANTIGEN PROSTATIC CHANGES DURING TREATMENT WITH FINASTERIDE OR DUTASTERIDE FOR BENIGN PROSTATIC HYPERPLASIA
    Arena, F.
    MINERVA UROLOGICA E NEFROLOGICA, 2013, 65 (03) : 211 - 216
  • [9] Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
    Josephina G. Kuiper
    Irene D. Bezemer
    Maurice T. Driessen
    Averyan Vasylyev
    Claus G. Roehrborn
    Fernie J. A. Penning-van Beest
    Ron M. C. Herings
    BMC Urology, 16
  • [10] Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
    Kuiper, Josephina G.
    Bezemer, Irene D.
    Driessen, Maurice T.
    Vasylyev, Averyan
    Roehrborn, Claus G.
    Penning-van Beest, Fernie J. A.
    Herings, Ron M. C.
    BMC UROLOGY, 2016, 16
12345